NGS Assays - carefully designed assays to meet your needs.

NGS Assays - carefully designed assays to meet your needs.

Molecular Diagnostic Tests

Information

BioVendor Group offers powerful, user-friendly, hybridization-based NGS solutions designed as true all-in-one workflows. Our assays include everything required for library preparation, bioinformatic analysis, and report generation, supported by GENOVESA, our proprietary bioinformatics platform used across all BioVendor Group NGS solutions for automated data processing, variant calling, annotation, database management, and comprehensive reporting. The epicGEN Solid Cancer & MSI Kit is a comprehensive solution for oncology diagnostics, combining solid tumor profiling with microsatellite instability (MSI) analysis. The MSI baseline is established using normal MS-Stable samples, ensuring robust and clinically relevant MSI assessment for precision oncology applications. The Hereditary Cancer NGS Assay is designed for the detection of germline variants associated with inherited cancer predisposition syndromes. It covers the complete coding sequences (CDS) of clinically relevant genes and enables the detection of SNVs, InDels, CNVs, and MSI, supporting comprehensive hereditary cancer risk assessment and informed clinical decision-making. The Clinical Exome Sequencing NGS Assay delivers broad coverage of clinically relevant genes across multiple disease areas, including oncology, enabling reliable variant detection and interpretation for clinical diagnostics and research.
BioVendor - Laboratorní medicína a.sS1.A39We are an international group of biotechnology companies with expertise in immunodiagnostics, molecular diagnostics, and radio-immunodiagnostics. Founded in 1992 in the Czech Republic, we have grown from a local company into a global innovator with in-house research, development, and production of in-vitro diagnostic (IVD) products, supported by an international distribution network. Our portfolio is structured around two complementary diagnostic pillars: Immunodiagnostics We provide a broad immunodiagnostic portfolio covering routine and specialized laboratory testing across key technologies. CLIA - Markers in autoimmunity, diabetes, gastrointestinal diseases and Infectious serology, available exclusively on the KleeYa ® platform, expanding testing possibilities MBA - Precision multiplex diagnostics for comprehensive antibody detection in autoimmune and infectious diseases. BLOT - Reliable, robust technology for precise detection of specific antibodies. ELISA - Complete portfolio for Infectious serology, immunology & endocrinology. RIA/IRMA - Proved radioimmunoassays for endocrinology including unique niche parameters. Antibodies - The foundation of immunoassays, driving performance across every diagnostic technology. Molecular Diagnostics In molecular diagnostics, BioVendor Group delivers solutions ranging from PCR-based assays to high-precision next-generation sequencing (NGS). RealFast™️ Assay - IVDR certified real-time PCR assays for rapid detection of clinically relevant genetic variants and CNVs, covering CVD and pharmacogenetics. StripAssay® - IVDR certified multiplex PCR and hybridization-based assays for simultaneous detection of clinically relevant genetic variants, covering Thalassemia and Cystic Fibrosis. NGS Assay - Targeted sequencing for oncology, hereditary diseases, and microbiome analysis with integrated bioinformatics. fastGEN™ - One-step PCR NGS library preparation for challenging oncology samples, including bioinformatic analysis. BioVendor Group - a group of companies (BioVendor LM, BioVendor R&D, TestLine, ViennaLab, DiaSource, BioVendor MDx)

Log in

See all the content and easy-to-use features by logging in or registering!